Brief: Biocartis: Publication Of New Study On Idylla EGFR Mutation Test
16/11/2021 06:09
Nov 16 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* PRESS RELEASE BIOCARTIS GROUP NV: NEW STUDY DEMONSTRATES
IDYLLA™
EGFR MUTATION TEST (CE-IVD) SHORTENS TIME TO PATIENT MANAGEMENT
DECISIONS FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER
Source text for Eikon: ID:nGNE7GNWQQ
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies